A Trial to Evaluate the Efficacy and Safety of Different Doses of KVD824 for Prophylactic Treatment of HAE Type I or II

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
A study to assess whether different doses of KVD824 are effective in preventing attacks of Hereditary Angiodedema Type I or Type II.
Epistemonikos ID: 14aeeb21838c6981c5be6eba43d764b63e1fbba5
First added on: May 09, 2024